Dr. Janet McGill is Professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at Washington University School of Medicine, and attending physician at Barnes-Jewish Hospital in St. Louis, Missouri. She is the principal investigator of the NIH funded GRADE study and the Insulin-Only Bionic Pancreas Pivotal Trial, and a sub-investigator on the RADIANT study, which hopes to discover genetic causes of diabetes. Dr. McGill has conducted over 220 clinical trials in type 1 and type 2 diabetes. She led WU in the PERL, WISDM and MOBILE studies. Dr. McGill has served on NIH review panels, steering committees and data safety and monitoring boards, and leads data safety committees locally and regionally. Dr. McGill has published over 200 peer-reviewed articles, numerous commentaries and editorials, 25 chapters, and she has edited four books. She has served on the editorial boards of several journals and has lectured nationally and internationally. She served on the board of directors of AACE and ACE, and is active in the Endocrine Society and ADA. She is a member of AOA, and has received the Distinguished Clinician Award, the Alumni Achievement Award and the Endocrine Fellows’ Teaching Award from her peers at Washington University.